Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

Rhea-AI Summary

Aligos Therapeutics, Inc. (Nasdaq: ALGS) will present at the 2023 Piper Sandler Healthcare Conference in New York on November 30, 2023, at 12:30 p.m. ET. Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO, will be the presenter. The webcast link and replay details are available on the Aligos investor section of the website. The management team will also participate in investor 1x1 meetings during the conference.

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, and the Aligos management team, will present at the 2023 Piper Sandler Healthcare Conference being held in New York on Thursday, November 30, 2023 at 12:30 p.m. ET.

Piper Sandler Healthcare Conference Information:

	Date	Thursday, November 30, 2023
	Time:	12:30 p.m. ET
	Presenter:	Lawrence Blatt, Ph.D., MBA, CEO of Aligos
	Webcast:	Link here

A replay of the session will be available following the conference for 90-days through the Aligos investor section of the website https://investor.aligos.com/.

The Aligos management team will also participate in investor 1x1 meetings during the conference. Please contact your Piper Sandler representative to schedule one-on-one meetings with Aligos during the conference.

About Aligos

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best in class therapeutics for nonalcoholic steatohepatitis (NASH) and viruses with high unmet medical need such as coronaviruses and chronic hepatitis B (CHB).

Media Contact
Veronica Eames
LifeSci Communications
veames@lifescicomms.com

Investor Contact
Corey Davis, Ph.D.
LifeSci Advisors
+1 212 915 2577
cdavis@lifesciadvisors.com

FAQ

What is the date of the 2023 Piper Sandler Healthcare Conference presentation by Aligos Therapeutics, Inc.?

The presentation will be on Thursday, November 30, 2023.

Who will be the presenter at the conference?

Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will be the presenter.

Where can I find the webcast link and replay details?

The webcast link and replay details will be available on the Aligos investor section of the website.

Will the Aligos management team participate in investor meetings during the conference?

Yes, the management team will participate in investor 1x1 meetings during the conference. Contact your Piper Sandler representative to schedule meetings with Aligos.